Cargando…
Pityriasis rosea, pityriasis rosea–like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination
Pityriasis rosea (PR), PR–like eruptions (PR-LE), and herpes zoster have been frequently reported during the COVID-19 pandemic and following COVID-19 vaccination. PR is a self-limiting exanthematous disease and herpes zoster is a treatable condition; therefore, their occurrence does not require disc...
Autores principales: | Drago, Francesco, Broccolo, Francesco, Ciccarese, Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801905/ https://www.ncbi.nlm.nih.gov/pubmed/35093476 http://dx.doi.org/10.1016/j.clindermatol.2022.01.002 |
Ejemplares similares
-
Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines
por: Drago, Francesco, et al.
Publicado: (2022) -
Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?
por: Drago, Francesco, et al.
Publicado: (2018) -
Pityriasis rosea during COVID-19 and its pathogenesis
por: Drago, Francesco, et al.
Publicado: (2022) -
Comment on a case of pityriasis rosea shortly after Moderna COVID-19 vaccination
por: Drago, Francesco, et al.
Publicado: (2022) -
Is a treatment for pityriasis rosea really needed?
por: Ciccarese, Giulia, et al.
Publicado: (2016)